Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

FENC holding history

Fennec Pharmaceuticals Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

FENC overviewAll 13F holders of FENCFull Q2 2026 holdings

Shares (Q2 2026)
4,709
Value
$50.6K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of FENC by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20264,709$50.6K<0.1%−1,763−27.2%ReducedHolders
Q1 20266,472$39.8K<0.1%+1,477+29.6%AddedHolders
Q4 20254,995$38.5K<0.1%−8,715−63.6%ReducedHolders
Q3 202513,710$128.3K<0.1%+686+5.3%AddedHolders
Q2 202513,024$108.1K<0.1%−13,230−50.4%ReducedHolders
Q1 202526,254$159.9K<0.1%+10,732+69.1%AddedHolders
Q4 202415,522$98.1K<0.1%+4,299+38.3%AddedHolders
Q3 202411,223$56.1K<0.1%+3,955+54.4%AddedHolders
Q2 20247,268$44.4K<0.1%−22,350−75.5%ReducedHolders
Q1 202429,618$329.4K<0.1%+9,649+48.3%AddedHolders
Q4 202319,969$224.1K<0.1%+9,979+99.9%AddedHolders
Q3 20239,990$75.0K<0.1%−542−5.1%ReducedHolders
Q2 202310,532$93.0K<0.1%+9,827+1,393.9%AddedHolders
Q1 2023705$5.87K<0.1%+641+1,001.6%AddedHolders
Q4 202264$614<0.1%−3,035−97.9%ReducedHolders
Q3 20223,099$26.0K<0.1%+3,035+4,742.2%AddedHolders
Q2 202264$00.0%−1,032−94.2%ReducedHolders
Q1 20221,096$6.00K<0.1%−6,681−85.9%ReducedHolders
Q4 20217,777$34.0K<0.1%+7,713+12,051.6%AddedHolders
Q3 202164$1.00K<0.1%−58,922−99.9%ReducedHolders
Q2 202158,986$430.0K<0.1%+18,417+45.4%AddedHolders
Q1 202140,569$252.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.